Vyvanse / Lisdexamfetamine → 🇨🇦 Canada

Full details

Vyvanse / Lisdexamfetamine restricted; documentation or permits may apply. Quantity guidance for Canada: Up to 90-day personal supply under CDSA Schedule I personal-use exemption. Documentation: Original prescription from licensed Canadian physician; Medication in original pharmacy-labelled packaging; Doctor's letter stating medical necessity (recommended). Enforcement in Canada carries fines from CAD 500 to CAD 5,000 under Customs Act R.S.C. 1985 c.1 s.12, s.153 (ordinary personal cases are handled as civil infringements). Restricted status means compliant carriage is achievable with the right paperwork and quantities; the practical risks are seizure, duty, and delay rather than criminal liability for a good-faith traveller. Arrival checks are carried out by Canada Border Services Agency (CBSA); when in doubt use the declare (red) channel — declared goods at worst attract duty or surrender, while undeclared goods attract penalties. Leaving Canada with vyvanse / lisdexamfetamine is a separate question: restricted — Vyvanse (lisdexamfetamine) is a controlled stimulant; personal export from Canada requires prescription documentation and stays within personal-use limits.

Leaving Canada with vyvanse / lisdexamfetamine

Lisdexamfetamine is a Schedule II-equivalent controlled stimulant under the Controlled Drugs and Substances Act; Precursor Control Regulations framework. Personal-use quantities (typically ≤30-90 days' supply) accompanied by the prescription and doctor's letter are generally permitted for export from Canada; above these limits a Health Canada authorisation for above-schedule quantities is required in advance. Destination-side treatment is the sharper risk — several countries (Japan requires advance permission; some jurisdictions ban amphetamine-class medicines outright) restrict arrival with stimulant ADHD medication, so verify the arrival rule for the same route.

OFFICIAL SOURCES · VERIFIED 2026-08-22